Ajanta Pharma Ltd’s shares were up 5 per cent at Rs 2,160 on the Bombay Stock Exchange in Friday’s intra-day trade after the company said its board would meet on December 28 to consider a share buyback plan.
“The meeting of the board of directors of the Company is scheduled on Tuesday, December 28, 2021, to consider a proposal for buy-back of equity shares including matters related /incidental to it,” Ajanta Pharma said.
- India’s Exports May Hit Record $800 Bn in 2025: Piyush Goyal
- Meta Expands AI-Powered Advantage+ Suite for Better Ad Performance
- Hexaware Technologies IPO GMP & Lot Size Details : Worth Investing Or Not?
- Infibeam Avenues’ RediffPay Secures NPCI Digital Payment License, Shares End Flat
- Gensol Engineering Secures Rs 968 Crore Order, Shares Jump 5%
Buyback is a corporate action in which a company buys back its shares from the existing shareholders, usually higher than the market price. When it buys back shares, the number of outstanding shares in the market reduces.
Stock Covered in the news
